Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Renal Impairment in Type 2 Diabetic Subjects

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
AstraZeneca
ClinicalTrials.gov Identifier:
NCT00554450
First received: November 5, 2007
Last updated: March 20, 2015
Last verified: March 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2008
  Primary Completion Date: October 2008 (Final data collection date for primary outcome measure)
Publications: